STADA Arzneimittel AG Logo

STADA Arzneimittel AG

A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.

SAZ | HM

Overview

Corporate Details

ISIN(s):
DE0007251803 (+1 more)
LEI:
529900FMTTLMH0P0DL10
Country:
Germany
Address:
Stadastraße 2 - 18, 61118 Bad Vilbel
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

STADA Arzneimittel AG is a global pharmaceutical company operating with a three-pillar strategy consisting of Generics, Consumer Healthcare, and Specialty Pharmaceuticals. The company is a leading European player in its core segments, ranking as the fourth-largest manufacturer of both generics and consumer healthcare products. Its Generics division focuses on providing affordable medicines. The Consumer Healthcare business is driven by a portfolio of strong regional and 'Local Hero' brands. The Specialty Pharmaceuticals segment develops and markets innovative treatments for specific conditions, including biologic therapies. With a heritage rooted in pharmacies and dating back to 1895, STADA's purpose is to be a trusted partner in caring for people's health.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for STADA Arzneimittel AG and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB

Automate Your Workflow. Get a real-time feed of all STADA Arzneimittel AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for STADA Arzneimittel AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway ULTI
Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia SKF
Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo
Develops and distributes prescription & consumer healthcare products in Europe and Asia.
Japan 4559

Talk to a Data Expert

Have a question? We'll get back to you promptly.